195 related articles for article (PubMed ID: 37773310)
1. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.
Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
[TBL] [Abstract][Full Text] [Related]
2. Development of a prediction model for gross residual in high-grade serous ovarian cancer by combining preoperative assessments of abdominal and pelvic metastases and multiparametric MRI.
Lu J; Cai S; Wang F; Wu PY; Pan X; Qiang J; Li H; Zeng M
Acad Radiol; 2023 Sep; 30(9):1823-1831. PubMed ID: 36587996
[TBL] [Abstract][Full Text] [Related]
3. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.
Li H; Cai S; Deng L; Xiao Z; Guo Q; Qiang J; Gong J; Gu Y; Liu Z
Eur Radiol; 2023 Aug; 33(8):5298-5308. PubMed ID: 36995415
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
Hinchcliff E; Paquette C; Roszik J; Kelting S; Stoler MH; Mok SC; Yeung TL; Zhang Q; Yates M; Peng W; Hwu P; Jazaeri A
Cancer Immunol Immunother; 2019 Sep; 68(9):1515-1526. PubMed ID: 31515669
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis.
Qi Y; Liu J; Wang X; Zhang Y; Li Z; Qi X; Huang Y
J Ovarian Res; 2024 Feb; 17(1):48. PubMed ID: 38389075
[TBL] [Abstract][Full Text] [Related]
7. A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer.
Chen HZ; Wang XR; Zhao FM; Chen XJ; Li XS; Ning G; Guo YK
Eur J Radiol; 2021 Dec; 145():110018. PubMed ID: 34773830
[TBL] [Abstract][Full Text] [Related]
8. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
10. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
He H; Jin Z; Dai J; Wang H; Sun J; Xu D
Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study.
Huang L; Lin W; Xie D; Yu Y; Cao H; Liao G; Wu S; Yao L; Wang Z; Wang M; Wang S; Wang G; Zhang D; Yao S; He Z; Cho WC; Chen D; Zhang Z; Li W; Qiao G; Chan LW; Zhou H
Eur Radiol; 2022 Mar; 32(3):1983-1996. PubMed ID: 34654966
[TBL] [Abstract][Full Text] [Related]
14. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
[TBL] [Abstract][Full Text] [Related]
15. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment.
Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
[TBL] [Abstract][Full Text] [Related]
17. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
[TBL] [Abstract][Full Text] [Related]
18. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer.
Zhang W; Fang M; Dong D; Wang X; Ke X; Zhang L; Hu C; Guo L; Guan X; Zhou J; Shan X; Tian J
Radiother Oncol; 2020 Apr; 145():13-20. PubMed ID: 31869677
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies.
Wu Q; Tian R; He X; Liu J; Ou C; Li Y; Fu X
Front Immunol; 2023; 14():1164408. PubMed ID: 37090728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
